Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GBA1 | P04062 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4509989 | 0.82 | KDM4E (0.44) | MEN1GBA1KMT2AMAPTALDH1A1 | |
| SCHEMBL5771717 | 0.80 | MEN1 (0.33) | MEN1GBA1KMT2A | |
| SCHEMBL5774361 | 0.73 | CDK4 (0.32) | KMT2AALDH1A1 | |
| SCHEMBL4872259 | 0.73 | CDK2 (0.44) | KMT2AALDH1A1 | |
| SCHEMBL4017611 | 0.70 | KDM4E (0.35) | MAPTALDH1A1LMNA | |
| SCHEMBL5283300 | 0.69 | CRHR1 (0.37) | MAPT | |
| SCHEMBL4017079 | 0.69 | CRHR1 (0.35) | ALDH1A1 | |
| SCHEMBL10528347 | 0.66 | KDM4E (0.47) | MEN1KMT2AMAPTALDH1A1LMNA | |
| SCHEMBL4875190 | 0.65 | CCNT1 (0.38) | MAPTALDH1A1LMNA | |
| SCHEMBL14338820 | 0.65 | ALDH1A1 (0.36) | MEN1KMT2AMAPTALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1718652-A2 | PYRAZOLOPYRIMIDINES FOR COMBATTING UNWANTED MICROORGANISMS | Bayer CropScience Aktiengesellschaft (DE) | 2006-11-08 | — | — | EP | disclosed |
| WO-2005082907-A2 | PYRAZOLOPYRIMIDINES FOR CONTROLLING UNDESIRED MICROORGANISMS | BAYER CROPSCIENCE AG (DE) | 2005-09-09 | — | — | WO | disclosed |